Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response

Conggang Zhang(Center for Life Sciences), Xuedong Liu(Qingdao University)
Journal of Biological Chemistry
July 4, 2017
Cited by 104


Related Papers